Tang et al. reported that MIR200CHG was highly expressed in breast cancer tissues and could promote breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-147, which seems to be contradictory to our conclusion. This evidence concerns the gene MIR200CHG and breast carcinoma.